We attened the 2205 ESMO Congress, that took place Oct 17-21, in Berlin, Germany. Review our poster and partner poster presentations below. Featured Presentations Scientific Posters We were proud to share ClearNote Health’s latest breakthroughs in epigenomic-based...
We will be attending the 17th Annual Next Generation Summit, taking place Aug18-20 in Washington, D.C. Don’t miss our presentation in the Early Cancer Surveillance track, with the topic: Multi- and Single-Cancer Early Detection: Validation of Improved Early...
Meet our team at the 15th Annual World Biomarker & CDx Summit | September 22-25, 2025 | Boston, MA. Learn more about the Virtuoso epigenomics platform, by ClearNote Health, which measures active disease biology from drug discovery through development, including...
Don’t miss our poster presentation at ASCO 2025. Colorectal cancer (CRC) is the third most common cancer worldwide and a leading cause of cancer mortality, with ~33% of patients developing metastases and a poor 5-year survival rate of ~15%. While surgical...
Join us at DDW25 to explore how ClearNote Health is harnessing the power of the epigenome to drive early pancreatic cancer detection and transform patient outcomes. 📍 Visit us at booth #5525 to learn more about the @Avantect Pancreatic Cancer Test – a simple,...
